McDonald Marguerite B, Barnett Melissa, Gaddie Ian B, Karpecki Paul, Mah Francis, Nichols Kelly K, Trattler William B
NYU Langone Medical Center, New York, NY, USA.
Tulane University Health Sciences Center, New Orleans, LA, USA.
Ophthalmol Ther. 2022 Feb;11(1):1-11. doi: 10.1007/s40123-021-00410-w. Epub 2021 Oct 28.
There are close to two billion individuals globally living with presbyopia. In spite of its ubiquitous and progressive nature, there is no widely accepted, formal guideline or consensus statement on the classification of presbyopia by degree of severity. A panel of leading eye care professionals representing both optometrists and ophthalmologists convened virtually to discuss and document their combined assessments from the body of literature and clinical practice expertise in this commentary. In light of emerging therapies, classifying presbyopia by mild, moderate, or advanced severity may help provide consistency of diagnosis among eye care providers and may aid in managing patient expectations with different treatment options.
全球有近20亿人患有老花眼。尽管老花眼具有普遍性和渐进性,但对于老花眼严重程度的分类,目前尚无广泛认可的正式指南或共识声明。一个由验光师和眼科医生组成的顶尖眼保健专业人员小组进行了线上会议,以讨论并记录他们结合文献资料和临床实践专业知识得出的综合评估结果。鉴于新出现的治疗方法,按轻度、中度或重度对老花眼进行分类,可能有助于在眼保健提供者之间实现诊断的一致性,并有助于管理患者对不同治疗方案的期望。